Vermillion Wealth Management’s Sotera Health SHC Stock Holding History

Vermillion Wealth Management’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$301	–	2295
2026 Q1	$301	Buy	+21	New	+$349	﹤0.01%	1179

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vermillion Wealth Management's SHC Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 21 shares — an estimated $301 sold.

Vermillion Wealth Management first reported a position in SHC in Q1 2026 and held it in 1 quarter. The position peaked at $301 in Q1 2026. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

Vermillion Wealth Management reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 21 Sotera Health shares in Q2 2026, an estimated $301.
Vermillion Wealth Management first reported a position in Sotera Health in Q1 2026 and held it in 1 quarter.
Vermillion Wealth Management's Sotera Health position peaked at $301 in Q1 2026.
316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.